Literature DB >> 15945510

Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review.

Lee E Moore1, Robin T Wilson, Sharan L Campleman.   

Abstract

Malignant kidney tumors account for approximately 2% of all new primary cancer cases diagnosed in the United States, with an estimated 30,000 cases occurring annually. Although a variety of agents, chemical and biological, have been implicated as causal agents in the development of renal cell carcinoma (RCC), the etiology remains enigmatic. The strongest association has been developed between cigarette smoking and renal cancer however consistent, positive associations between RCC and obesity, diabetes, and hypertension have also been reported. In addition, more recent investigations of familial kidney cancer syndromes indicate that a strong genetic component contributes to RCC development. Several genes have been identified through investigation of familial kidney cancer syndromes. This review article describes recent trends in RCC incidence and the currently identifiable etiological causes that account for approximately half of the RCC cases diagnoses. The remainder of this review then focuses on additional risk factors that have thus far not been well examined but may be helpful in explaining the increasing incidence trends and the geographic or racial variation observed nationally and worldwide.

Entities:  

Mesh:

Year:  2005        PMID: 15945510     DOI: 10.1081/cnv-200055962

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  31 in total

1.  HIV-induced kidney cell injury: role of ROS-induced downregulated vitamin D receptor.

Authors:  Divya Salhan; Mohammad Husain; Ashaan Subrati; Rohan Goyal; Tejinder Singh; Partab Rai; Ashwani Malhotra; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-30

2.  Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis.

Authors:  Jessica Clague; Jie Lin; Adrian Cassidy; Surena Matin; Nizar M Tannir; Pheroze Tamboli; Christopher G Wood; Xifeng Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-24       Impact factor: 4.254

3.  Cancers of the urinary tract among American Indians and Alaska Natives in the United States, 1999-2004.

Authors:  Robin Taylor Wilson; Lisa C Richardson; Janet J Kelly; Judith Kaur; Melissa A Jim; Anne P Lanier
Journal:  Cancer       Date:  2008-09-01       Impact factor: 6.860

4.  Kidney cancer incidence and mortality among American Indians and Alaska Natives in the United States, 1990-2009.

Authors:  Jun Li; Hannah K Weir; Melissa A Jim; Sallyann M King; Reda Wilson; Viraj A Master
Journal:  Am J Public Health       Date:  2014-04-22       Impact factor: 9.308

5.  Comprehensive Analysis of Factors Affecting Post-partial Nephrectomy Renal Global Function.

Authors:  Takehiro Sejima; Tetsuya Yumioka; Noriya Yamaguchi; Hideto Iwamoto; Toshihiko Masago; Shuichi Morizane; Masashi Honda; Atsushi Takenaka
Journal:  Yonago Acta Med       Date:  2017-06-26       Impact factor: 1.641

6.  Hypertension and obesity and the risk of kidney cancer in 2 large cohorts of US men and women.

Authors:  Kristen M Sanfilippo; Kathleen M McTigue; Christian J Fidler; James D Neaton; Yuefang Chang; Linda F Fried; Simin Liu; Lewis H Kuller
Journal:  Hypertension       Date:  2014-03-17       Impact factor: 10.190

7.  A prospective study of one-carbon metabolism biomarkers and risk of renal cell carcinoma.

Authors:  Todd M Gibson; Stephanie J Weinstein; Susan T Mayne; Ruth M Pfeiffer; Jacob Selhub; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes; Rachael Stolzenberg-Solomon
Journal:  Cancer Causes Control       Date:  2010-04-10       Impact factor: 2.506

8.  Renal carcinogenesis in models of diabetes in rats: metabolic changes are closely related to neoplastic development.

Authors:  F Dombrowski; L Klotz; P Bannasch; M Evert
Journal:  Diabetologia       Date:  2007-10-19       Impact factor: 10.122

9.  Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenib.

Authors:  Chris Coppin
Journal:  Biologics       Date:  2010-05-25

10.  Dietary fat and risk of renal cell carcinoma in the USA: a case-control study.

Authors:  Kaye E Brock; Gloria Gridley; Brian C-H Chiu; Abby G Ershow; Charles F Lynch; Kenneth P Cantor
Journal:  Br J Nutr       Date:  2008-09-12       Impact factor: 3.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.